Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis.

Andrew M BlumenfeldPeter J GoadsbyDavid W DodickSusan HutchinsonChengcheng LiuMichelle FinneganJoel M TrugmanArmin Szegedi

Published in: Headache (2021)

Ubrogepant efficacy and tolerability did not differ for the acute treatment of migraine in participants classified as triptan responders, triptan-insufficient responders, and triptan-naïve based on their historical experience with triptans.

Keyphrases

liver failure
clinical trial
drug induced
randomized controlled trial
aortic dissection
double blind
combination therapy
placebo controlled
acute respiratory distress syndrome
extracorporeal membrane oxygenation